Akebia Therapeutics (AKBA)
NASDAQ:AKBA
Holding AKBA?
Track your performance easily

Akebia Therapeutics (AKBA) Financial Statements

1,305 Followers

Akebia Therapeutics Financial Overview

Akebia Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.22; its P/E ratio is -8.79; Akebia Therapeutics is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 37.43M$ 43.65M$ 32.61M$ 56.07M$ 42.05M
Gross Profit$ 32.28M$ 35.61M$ 21.00M$ 27.69M$ 24.04M
EBIT$ -20.04M$ -8.58M$ -17.27M$ 2.03M$ -13.08M
EBITDA$ -10.68M$ 818.00K$ -7.91M$ 16.88M$ -3.94M
Net Income Common Stockholders$ -20.04M$ -8.58M$ -17.98M$ -47.00K$ -14.49M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 34.02M$ 39.50M$ 41.96M$ 42.92M$ 46.53M
Total Assets$ 207.14M$ 220.20M$ 225.48M$ 241.70M$ 235.00M
Total Debt$ 43.29M$ 44.33M$ 37.78M$ 43.63M$ 52.84M
Net Debt$ 9.27M$ 4.83M$ -4.18M$ 705.00K$ 6.31M
Total Liabilities$ 257.54M$ 253.95M$ 252.74M$ 272.29M$ 274.42M
Stockholders Equity$ -50.40M$ -33.75M$ -27.26M$ -30.58M$ -39.42M
Cash Flow-
Free Cash Flow$ -6.70M$ -10.10M$ -19.43M$ -2.31M$ -7.17M
Operating Cash Flow$ -6.70M$ -10.07M$ -19.43M$ -2.31M$ -7.17M
Investing Cash Flow$ -2.00K$ -29.00K---
Financing Cash Flow$ 1.22M$ 7.64M$ 18.48M$ -1.29M$ 50.00K
Currency in USD

Akebia Therapeutics Earnings and Revenue History

Akebia Therapeutics Debt to Assets

Akebia Therapeutics Cash Flow

Akebia Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis